Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5269664
Max Phase: Preclinical
Molecular Formula: C22H22N4O2
Molecular Weight: 374.44
Associated Items:
ID: ALA5269664
Max Phase: Preclinical
Molecular Formula: C22H22N4O2
Molecular Weight: 374.44
Associated Items:
Canonical SMILES: O=C(c1cccnc1-c1ccncc1)N1CCC(O)(Cc2ccccn2)CC1
Standard InChI: InChI=1S/C22H22N4O2/c27-21(19-5-3-11-25-20(19)17-6-12-23-13-7-17)26-14-8-22(28,9-15-26)16-18-4-1-2-10-24-18/h1-7,10-13,28H,8-9,14-16H2
Standard InChI Key: CFUZDIHJEMMDOQ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 374.44 | Molecular Weight (Monoisotopic): 374.1743 | AlogP: 2.75 | #Rotatable Bonds: 4 |
Polar Surface Area: 79.21 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 5.21 | CX LogP: 0.94 | CX LogD: 0.93 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.76 | Np Likeness Score: -1.00 |
1. Koike T, Yoshikawa M, Ando HK, Farnaby W, Nishi T, Watanabe E, Yano J, Miyamoto M, Kondo S, Ishii T, Kuroita T.. (2021) Discovery of Soticlestat, a Potent and Selective Inhibitor for Cholesterol 24-Hydroxylase (CH24H)., 64 (16.0): [PMID:34387987] [10.1021/acs.jmedchem.1c00864] |
Source(1):